Sudden loss in kidney function and increasing serum creatinine level without loss of urine are observed in ICU-acquired acute kidney. It is observed in people who have been admitted in the ICU for a particular treatment.
The ICU-acquired acute kidney treatment market is segmented based on type, therapy type and regions. On the basis on type, the market is divided into pre-renal, intrinsic-renal and post-renal. Based on therapy type, the market is segmented into intermittent hemodialysis, continuous renal replacement therapy and sustained low-efficiency dialysis.
With the COVID-19 breakout in December 2019, the disease has affected more than 200 countries. Therefore, it is important to take this into consideration while addressing ICU-acquired acute kidney treatment market.
The disease may have led to temporary lag in the ICU-acquired acute kidney treatment market, but in the long run the ICU-acquired acute kidney treatment market is expected to pace up and flourish at a significant rate during the forecast period 2020-2030.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12579
ICU-acquired Acute Kidney Treatment Market: Drivers and Restraints
Increasing prevalence of lifestyle-related diseases such as obesity & diabetes and rising incidence of renal failure cases are the major factors that are expected to drive the growth of the ICU-acquired acute treatment market.
Moreover, the rising geriatric population, increasing health expenditure among the population, increasing initiatives by the government to manage chronic kidney diseases and technological advancement in the healthcare sector may also boost the growth of the ICU-acquired acute treatment market.
However, stringent rules by various health authority for product approvals and low awareness regarding treatment in developing and underdeveloped countries may hinder the growth of the ICU-acquired acute kidney treatment market.
ICU-acquired Acute Kidney Treatment Market: Overview
On the basis of treatment type,the ICU-acquired acute kidney treatment market is segmented into pre-renal, intrinsic-renal and post renal. In this segment, intrinsic-renal is expected to be the major contributor of revenue and will lead to the growth of ICU-acquired acute kidney treatment market.
On the basis of therapy type, the ICU-acquired acute kidney treatment market is segmented into intermittent hemodialysis, continuous renal replacement therapy and sustained low-efficiency dialysis. In this segment, intermittent hemodialysis may continue to grow as it is highly effective in achieving solute removal.
ICU-acquired Acute Kidney Treatment Market: Regional-Wise
The global ICU-acquired acute kidney treatment market is segmented into 5 regions i.e. North America, Latin America, Europe, Asia-Pacific and Middle East &Africa.
North America is expected to dominate the ICU-acquired acute kidney treatment market in terms of revenue during the forecast period due to growing no. of research activities and availability of drugs for treatment of the disease in this region.
Europe is expected to be 2nd highest contributor in terms of revenue in the ICU-acquired acute kidney treatment market. On the other hand, Asia Pacific is expected to experience fastest growth in the ICU-acquired acute kidney treatment market as a result of rising no. of kidney disorders, increasing geriatric population and higher investment for better healthcare facilities in countries in this region.
The growth of the ICU-acquired acute kidney treatment market is expected to be limited in the Middle East & Africa due to slow economic growth and limited development in healthcare sector.
ICU-acquired Acute Kidney Treatment Market: Key players
Some of the players identified in the ICU-acquired acute kidney treatment market include:
- Quark Pharmaceuticals Inc.
- Fresenius medical care AG & Co. KGaA
- B. Braun Melsungeb AG
- Baxter international, Inc.
- Angion Biomedical Corp
- LG chem
- Asahi Kasei medical Co. Ltd
For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-12579
Why Future Market Insights?
• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com